States

This report considers issues related to acute and chronic pain management and substance use disorders (SUD). It answers two guiding questions: (1) What are the priority gaps in QM science that need to be filled in order to reduce opioid use disorders (OUD

This toolkit, supported by funding from the Centers for Disease Control and Prevention (CDC) and Bloomberg Philanthropies, provides correctional administrators and health care providers recommendations and tools for implementing medication-assisted treatm

Understand the basics of addiction, including how it affects the brain, why some people are more susceptible to developing an addiction, and how addiction can be prevented and treated.

Provides policymakers, State and local officials, and other community stakeholders with key questions to consider before engaging in efforts to increase access to MAT for addiction in their communities

Highlights the different types of opioids and medication-assisted treatment.

Provides information about when healthcare professionals are legally allowed to disclose some health information related to OUD without a patient's permission.

Provides a list of data sources to assist agencies, nonprofit groups, organizations, community groups, and coalitions with collecting and assessing data on opioid use.

Provides information about the 2018 Arizona Opioid Epidemic Act for pharmacists and prescribers of opioids, including legal obligations.

Provides strategies to build support for expanding the use of medication-assisted treatment (MAT) and resources for securing buy-in.

Provides facts about the benefits of using PDMPs for prescribers, pharmacists, patients, and regulatory and law enforcement agencies.